• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

Botox impacts brain? Italian animal study raises safety concerns about botulinum toxin

A recent animal study has shown that botulinum toxin injections can travel through retrograde axonal transport to unintended sites, including those in the brain, according to researchers at the Italian National Research Council's Istituto di Neuroscienze.

Key Points

Pisa, Italy - A recent animal study has shown that botulinum toxin injections can travel through retrograde axonal transport to unintended sites, including those in the brain, according to researchers at the Italian National Research Council's Istituto di Neuroscienze. For the study, researchers injected 48 rats, and three days later, found evidence of robust neurotoxin activity on the contralateral side of the hippocampus (Antonucci F, et al. J Neurosci. 2008 Apr 2;28(14):3689-3696).

"Our findings provide the first evidence for a mechanism by which botulinum toxin A can gain access to the central nervous system after peripheral administration," the authors write.

However, "The study authors used a laboratory preparation of botulinum toxin that was different than Botox (Allergan)," says Caroline Van Hove, Allergan's vice president of corporate communications.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.